Search results for "GI bleeding"
Apixaban associated with lower risk of GI bleeding compared to other DOACs
Apixaban users experienced similar rates of ischemic stroke or systemic embolism, intracranial hemorrhage, and all-cause mortality as patients taking other direct oral anticoagulants (DOACs), a retrospective analysis found.
https://immattersacp.org/weekly/archives/2022/11/01/1.htm
1 Nov 2022
New UTI treatment, AI sepsis risk calculator approved
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2024/06/fda.htm
1 Jun 2024
Anticoagulants compared for associated risk of hospitalization due to upper GI bleeding
Proton-pump inhibitor cotherapy significantly reduced risk among patients on anticoagulation, a cohort study found.
https://immattersacp.org/weekly/archives/2018/12/11/4.htm
11 Dec 2018
Managing DOACs in primary care
Primary care physicians play a crucial role in ongoing anticoagulation management, including educating patients about the signs of venous thromboembolism.
https://immattersacp.org/archives/2022/04/managing-doacs-in-primary-care.htm
1 Apr 2022
Restarting warfarin after GI bleeding associated with better outcomes
Patients previously on warfarin who don't resume the therapy soon after a gastrointestinal (GI) bleeding event may have a higher risk for thrombosis and death, according to a new study.
https://immattersacp.org/weekly/archives/2012/09/25/5.htm
25 Sep 2012
Short courses of steroids linked to severe adverse events
Courses of oral corticosteroids for 14 or fewer days are associated with GI bleeding, sepsis, and heart failure, with the highest risks occurring within the first month of initiation, according to a Taiwanese study.
https://immattersacp.org/weekly/archives/2020/07/07/2.htm
7 Jul 2020
Dabigatran recalled, dense-breast notification required
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/05/dabigatran-recalled-dense-breast-notification-required.htm
1 May 2023
AGA clinical practice update offers guidance on PPI deprescribing
All patients taking a proton-pump inhibitor (PPI) should have a regular review and documentation of ongoing indications for use, which should be the responsibility of the primary care clinician, the American Gastroenterological Association (AGA) said.
https://immattersacp.org/weekly/archives/2022/02/22/4.htm
22 Feb 2022
Over-the-counter test for flu, COVID-19 authorized
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/04/over-the-counter-test-for-flu-covid-19-authorized.htm
1 Apr 2023
Dabigatran may interact with BP meds in patients with afib and normal kidney function
U.S. guidance currently recommends a lower dabigatran dose in those taking P-glycoprotein inhibitors only if kidney function is impaired.
https://immattersacp.org/weekly/archives/2020/04/28/4.htm
28 Apr 2020